Privacy Policy

Amgen Astellas BioPharma K.K. (“AABP”) deeply recognizes the importance of protecting personal information and complies strictly with laws and regulations related to personal information, endeavoring to handle personal information appropriately and manage personal information safely in order for the company as a whole to fulfill the trust and expectations of society.

AABP shall handle personal information in accordance with the following items.

1.Collection of Personal Information

When obtaining personal information directly from individuals, AABP shall notify the person of the purpose for which the personal information is to be used when the information is provided. In addition, when collecting personal information via other methods, the information shall be collected within the scope necessary for achieving the utilization purpose for the information as disclosed in advance on the AABP website. In the case that personal information is acquired for a utilization purpose that has not been disclosed in advance, the person to whom the information belongs shall be notified immediately of the purpose for using the personal information or the purpose shall be publicly disclosed.

2.Use of Personal Information

AABP shall give notice of personal information the company has collected and use the information for the purposes of utilization disclosed in advance on the AABP website; usage of the collected information shall not exceed the scope necessary for achieving these purposes of utilization without the consent of the person to whom the information belongs.

In the case that handling of personal information is outsourced to a third party, a contractor capable of managing the personal information appropriately shall be selected and necessary matters for personal information protection shall be agreed between AABP and the contractor. In addition, personal information protection shall be implemented thoroughly through appropriate monitoring and management regarding the handling of personal information. In the case that personal information is utilized jointly by AABP and a third party, matters that are prescribed by law such as the scope of people jointly using the information shall be notified to the person to whom the information belongs or publicly disclosed on the AABP website.

Personal information that AABP may collect may be processed in Japan or in another country (including the United States of America or countries within or outside of the European Union) in which AABP, one of its affiliates, or one of the third parties with whom AABP has a relationship, is located. Some countries may have different data protection standards than Japan. AABP will take reasonable measures, in line with industry standards, to ensure that personal information will be treated in accordance with this personal information protection policy.

Where personal information furnished to or collected by AABP originates from another country, including member countries of the European Union or European Economic Area (the “EEA”), Switzerland and/or Russia, AABP shall comply with the applicable data privacy laws of the originating country with regards to processing of such personal information.

3.Providing Personal Information to a Third Party

Except for the cases listed below, AABP shall not provide personal information to a third party.

4.Safe Management of Personal Information

With regard to personal information (personal data) in a form that can be easily searched, such as in a database, AABP shall maintain the integrity of the personal information and manage the information safely. In addition, AABP shall prevent loss, destruction, falsification, leakage outside the company, and illegal access from outside of the personal information, implementing strict security measures. For certain sites and content, SSL encrypted communication is employed.

5.Disclosure, Amendment, Discontinuation of Use, and Erasure of Personal Data

In the case that a request is made to disclose, amend, suspend use of, or erase personal data held by AABP. AABP shall respond as necessary within reason after first confirming with the person to whom the information belongs.

6.Organization and Structure

AABP shall appoint staff to be responsible for personal information for the company overall, and shall implement appropriate supervision of staff handling personal information as well as provide training in order to ensure the protection of personal information.

7.Enquiries

In the case that AABP receives an enquiry or complaint about the company’s handling of personal information, AABP endeavors to take appropriate measures as swiftly as possible. Enquiries regarding personal information may be made by either telephone, email or postal mail.

Contact Information
E-mail:privacyoffice@aabp.co.jp
Tel: +81-3-5293-9900

Amgen Astellas BioPharma K.K.
Sapia Tower, 1-7-12 Marunouchi,
Chiyoda-ku, Tokyo 100-0005, Japan

8.Review of Private Information Protection Policy

In order to further enhance its handling of personal information, AABP shall continually review and improve its personal information protection policy. Thus, AABP reserves the right to change the terms of this personal information protection policy at any time by posting revisions to the AABP website in advance.

Purposes of Utilization of Personal Information

In addition to acquiring personal information for specified purposes of utilization (Article 18 Paragraph 1 of the Act on the Protection of Personal Information), AABP holds and uses personal information appropriately within the scope necessary for conducting our business activities (Article 24, Paragraph 1 of the Act on the Protection of Personal Information) in order to make the information available for use for the business activities prescribed in the company’s Articles of Incorporation, such as “the manufacture, sale, and import/export, etc., of drugs, quasi-drugs, drugs for animals, experimental drugs, heavy chemicals, pesticides, and other chemical products”.

The purposes for AABP utilizing personal information are as follows.

1.Personal Information Concerning Physicians, Dentists, Pharmacists, Pharmacies/Drugstores, and Other Medical Personnel

2.Personal Information Regarding Employees of Companies that Sell Drugs, etc.

3.Personal Information Related to Researchers in the Field of Biology, Including Medicine and Pharmacy

4.Personal Information Regarding Patients and Participants in Clinical Trials (Trial Subjects)

5.Personal Information Related to People Whom Contacted the Company Via the Public Relations Division, and other Contact Offices

6.Personal Information Regarding Employees of Outsourcing Contractors, Consultancy Companies, and Business Partners (including organizations in which the company has membership and related public agencies)

7.Personal Information Regarding People Involved in the Mass Media, Securities Analysts, and Investors

 

8.Personal Information Regarding People Seeking Employment

9.Personal Information Regarding Workers (current or former employees)

Shared Use of Personal Data

1.Shared use of personal information with Nihon Ultmarc Inc. and its member entities

Amgen Astellas BioPharma K.K. (AABP) shares and uses a database (hereinafter “medical database (MDB)”) containing basic information about medical facilities, pharmacies, drugstores and physicians and pharmacists working in these facilities throughout Japan with specific medical companies.

2.Items of personal data jointly used

A) Doctor Computer File (DCF)
Following items from personal information contained in records for physicians and facilities of Japan involved in medical care including hospitals, general medical clinics, healthcare facilities for the elderly, welfare facilities, and public health centers

B) Drug Store File (DSF)
Following items from personal information contained in records for pharmacies, licensed drug distributors, general distributors, and facilities such as of merchandisers involved in the sale and distribution of drugs in Japan

3.Scope of entities with which such data will be shared and used

The industries in the following segments use the MDB for the purpose of “protecting the lives and bodies of patients and improving the public health.”

4.Purpose of use of such data

The purpose of use of the MDB is for “protecting the lives and bodies of patients and improving the public health.”
The database is used for: providing, collecting, and studying necessary information in fulfilling the duties as physicians, dentists, and pharmacists; research and businesses with the purpose of contributing to the society in the fields of medicine, welfare, and health; and associated tasks related to the aforementioned activities.

5.Name of the entity responsible for the administration of the MDB

Nihon Ultmarc Inc.
2-45-1 Nihonbashi Hamacho, Chuo-ku, Tokyo 103-0007 Japan

Shared Use of Personal Data with Amgen Inc., Astellas Pharma Inc. and Group Companies

1. AABP makes shared use between Amgen Inc., Astellas Pharma Inc. and group companies of the personal information about customers including physicians required to conduct the manufacture and sale of medicines.

2.Items of personal data jointly used

A. Personal data related to personal information of physicians, dentists, pharmacists, pharmacies and drugstores, and other healthcare professionals:

B. Personal data related to personal information of the company’s executives and employees (including assigned employees and retirees):

C. Personal data of the families of the company’s executives and employees (including loan employees and retirees):

D. Personal data other than the above:

3.Scope of entities with which such information will be shared and used

Amgen Inc. and its group companies
Astellas Pharma Inc. and its group companies

4.Purposes of use

For the notified purpose of use of the personal information

5.Name of the entity responsible for the management of personal information

Amgen Astellas BioPharma K.K.

Method for Requesting Disclosure of Personal Information

1.Requests Related to Personal Information from the Person to whom the Information Belongs

AABP shall respond appropriately in accordance with the following procedures in response to requests related to personal information from the person to whom the information belongs.

1) Disclosure

In the case that a request is made for the disclosure of personal information from the person to whom the information belongs, except for in the following cases, AABP shall respond promptly to the request after first confirming that the person making the request is actually the person to whom the information belongs.

2) Notification of purposes of utilization

In the case that a request is made for notification of the purposes of utilization of personal information from the person to whom the information belongs, AABP shall respond promptly to the request after first confirming that the person making the request is actually the person to whom the information belongs.
Please understand that in certain cases, requests for notification of the purpose of utilization of personal information cannot be fulfilled.

3) Amendment/Addition/Deletion

In the case that a request is made for the amendment/addition/deletion of personal information from the person to whom the information belongs, AABP shall respond promptly to the request after first confirming that the person making the request is actually the person to whom the information belongs.
Please understand that in certain cases, requests for the amendment/addition/deletion of personal information cannot be fulfilled.

4) Suspension of usage/erasure

In the case that a request is made for the suspension of usage/erasure of personal information from the person to whom the information belongs, AABP shall respond promptly to the request after first confirming that the person making the request is actually the person to whom the information belongs.
Please understand that in certain cases, requests for the suspension of usage/erasure of personal information cannot be fulfilled.

2.How to Make a Request

AABP accepts requests regarding personal information only via the methods prescribed below. According to the content of the request, please complete the necessary items on the appropriate request form, attach the prescribed documents for confirming your identity as the person to whom the information belongs, and send to the address given below, enclosing a stamp for reply postage (the reply to your request will be sent via certified mail, so please include an 800 yen stamp for certified mail postage). We will respond once we have confirmed that the request is from the person to whom the information belongs. (Postage shall be borne by the sender of the request.)

Download stored personal data utilization purpose notice/disclosure request form
(Please use this form when making multiple requests at the same time.)

Download stored personal data disclosure request form

Download stored personal data amendment request form

Download stored personal data suspension of usage request form

Note: In the case that it is not possible for you to print out the form(s), please send an email to the address or call the number listed under the “Address for Sending Requests.” The required forms will be sent to the address provided by the person to whom the personal information belongs.

Documents for Verifying the Identity of the Person to whom the Information Belongs

1) Request made by the person to whom the information belongs
Provide copies of two (2) or more of the following official certificates.

2) Request made by a proxy for the person to whom the information belongs

Address for Sending Requests
privacyoffice@aabp.co.jp
Tel: +81-3-5293-9900

Amgen Astellas BioPharma K.K.
Sapia Tower, 1-7-12 Marunouchi,
Chiyoda-ku, Tokyo 100-0005, Japan

3.Replies to Requests

A written reply shall be sent via certified mail to the address of the person to whom the information belongs as provided in the documents for verifying the identity of that person to whom the information belongs (copies of official certificates).
 
Replies shall be sent within the number of days from the date of receipt of the request as specified below. (However, please understand that replies may be delayed for unavoidable reasons.)
1.Within 14 days (disclosure/notification of utilization purpose)
2.Within 30 days (amendment/addition/deletion/suspension of usage/erasure)